Sarah A Best

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Future oncology (London, England)

Biology

Cell death and differentiation

Oncogene

Walter and Eliza Hall Institute of Medical Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Walter and Eliza Hall Institute of Medical Research Feb 01 2016

Australia

Postdoctoral Research Fellow :: ACRF Stem Cells and Cancer Division

Publications

Cain Craig Truman Clark, Monique Topp, Mark Rosenthal, Robert Tobler, Saskia Freytag, Sarah A Best, James R Whittle, Katharine J Drummond
A perioperative study of Safusidenib in patients with IDH1 -mutated glioma. Future oncology (London, England) (2024)
Cain Craig Truman Clark, Monique Topp, Mark Rosenthal, Robert Tobler, Saskia Freytag, Sarah A Best, James R Whittle, Katharine J Drummond
A perioperative study of Safusidenib in patients with IDH1 -mutated glioma. Future oncology (London, England) (2024)
Liam M Furst, Enola M Roussel, Ryan F Leung, Ankita M George, Sarah A Best, James R Whittle, Ron Firestein, Maree C Faux, David D Eisenstat
The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models. Biology 13 (6) (2024)
Liam M Furst, Enola M Roussel, Ryan F Leung, Ankita M George, Sarah A Best, James R Whittle, Ron Firestein, Maree C Faux, David D Eisenstat
The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models. Biology 13 (6) (2024)
Rafik Boudra, Bethany L Patenall, Sandra King, Diana Wang, Sarah A Best, Joo Yeon Ko, Shuyun Xu, Maria G Padilla, Chrysalyne D Schmults, Steven R Barthel, Christine G Lian, Matthew R Ramsey
PRMT1 Inhibition Selectively Targets BNC1-Dependent Proliferation, but not Migration in Squamous Cell Carcinoma. bioRxiv : the preprint server for biology (2023)
Tianyao Lu, Lutz Freytag, Vinod K Narayana, Zachery Moore, Shannon J Oliver, Adam Valkovic, Brunda Nijagal, Amanda L Peterson, David P de Souza, Malcolm J McConville, James R Whittle, Sarah A Best, Saskia Freytag
Matrix Selection for the Visualization of Small Molecules and Lipids in Brain Tumors Using Untargeted MALDI-TOF Mass Spectrometry Imaging. Metabolites 13 (11) (2023)
Joel J D Moffet, Oluwaseun E Fatunla, Lutz Freytag, Jurgen Kriel, Jordan J Jones, Samuel J Roberts-Thomson, Anna Pavenko, David K Scoville, Liang Zhang, Yan Liang, Andrew P Morokoff, James R Whittle, Saskia Freytag, Sarah A Best
Spatial architecture of high-grade glioma reveals tumor heterogeneity within distinct domains. Neuro-oncology advances 5 (1) (2023)
Lahiru Gangoda, Robyn L Schenk, Sarah A Best, Christina Nedeva, Cynthia Louis, Damian B D'Silva, Kirsten Fairfax, Andrew G Jarnicki, Hamsa Puthalakath, Kate D Sutherland, Andreas Strasser, Marco J Herold
Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis. Cell death and differentiation (2021)
Sarah A Best, Cassandra J Vandenberg, Etna Abad, Lachlan W Whitehead, Laia Guiu, Sheryl Ding, Margs S Brennan, Andreas Strasser, Marco J Herold, Kate D Sutherland, Ana Janic
Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis. Cell death & disease 11 (10) (2020)
Sarah A Best, Sheryl Ding, Ariena Kersbergen, Xueyi Dong, Ji-Ying Song, Yi Xie, Boris Reljic, Kaiming Li, James E Vince, Vivek Rathi, Gavin M Wright, Matthew E Ritchie, Kate D Sutherland
Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma. Nature communications 10 (1) (2019)
Lahiru Gangoda, Charis E Teh, Michael A Dengler, Sarah A Best, Clare E Weeden, Lin Tai, Erinna F Lee, Walter D Fairlie, Kate D Sutherland, Leonard C Harrison, Daniel H D Gray, Andreas Strasser, Marco J Herold
Characterization of a novel human BFL-1-specific monoclonal antibody. Cell death and differentiation 27 (2) (2019)
Sarah A Best, Kate D Sutherland
"Keaping" a lid on lung cancer: the Keap1-Nrf2 pathway. Cell cycle (Georgetown, Tex.) 17 (14) (2018)
Sarah A Best, Cassandra R Harapas, Ariena Kersbergen, Vivek Rathi, Marie-Liesse Asselin-Labat, Kate D Sutherland
FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium. Oncogene 37 (46) (2018)

Sarah A Best.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sarah A Best